Annual report [Section 13 and 15(d), not S-K Item 405]

Organization (Details Narrative)

v3.26.1
Organization (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 17, 2026
Dec. 17, 2025
Jun. 18, 2025
Jan. 29, 2025
Jan. 30, 2024
Feb. 28, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 16, 2025
OrganizationLineItems [Line Items]                  
Stockholders' Equity, Reverse Stock Split   1-for-25 reverse stock split              
Common Stock, Par or Stated Value Per Share   $ 0.0001         $ 0.0001 $ 0.0001  
Common Stock, Shares, Issued   2,280,114         2,572,114 148,308 56,999,223
Common Stock, Shares, Outstanding   2,279,914         2,571,914 148,108 56,994,223
Common Stock, Shares Authorized   1,000,000,000         1,000,000,000 100,000,000  
Accumulated deficit             $ 100,783,033 $ 87,219,199  
Net loss             13,563,834 11,850,118  
Net cash used in operating activities             11,385,195 11,245,042  
Cash and cash equivalents             $ 5,536,955 $ 1,191,325  
Net proceeds           $ 200,000      
Purchase Agreement [Member]                  
OrganizationLineItems [Line Items]                  
Number of shares sold     572,400 41,239 19,040        
Purchase Agreement [Member] | Subsequent Event [Member]                  
OrganizationLineItems [Line Items]                  
Number of shares sold 86,956                
Proceeds from private placement $ 200,000